Stockscreener 앱 받기
0.796
1.23%
-0.0099
시간 외 거래:
.81
0.014
+1.76%
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
GUTSFractyl Health Inc Options - Finviz
Fractyl Health Price Target Announced at $4.00/Share by Craig-Hallum - Moomoo
GUTS Initiates Coverage by Fractyl Health -- Price Target Set at $4.00 - GuruFocus
Fractyl Health Initiated at Buy by Craig-Hallum - Moomoo
Craig-Hallum initiates Fractyl Health stock coverage with buy rating By Investing.com - Investing.com India
Craig-Hallum initiates Fractyl Health stock coverage with buy rating - Investing.com
Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target - Moomoo
Fractyl Health, Inc. Actuals & Estimates (NASDAQ:GUTS) - TradingView
GUTS Forecast — Price Target — Prediction for 2027 - TradingView
FRACTYL HEALTH INC (GUTS) Stock Chart - ChartMill
GUTS Q1 2026 Earnings: EPS Beat Amid Pre-Revenue Stage; Stock Declines 4.4%GAAP Earnings Report - Město Břeclav
Fractyl Health Inc (GUTS) Institutional Confidence - TradingKey
Fractyl Health Inc (GUTS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Fractyl Health Inc (GUTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fractyl Health Inc (GUTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fractyl Health Inc (GUTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fractyl Health Inc (GUTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan
Fractyl Health director Ajay Royan buys $19,596 in company stock - Investing.com UK
Fractyl Health director Ajay Royan buys $19,596 in company stock By Investing.com - Investing.com UK
Fractyl Health (NASDAQ: GUTS) director adds 23,000 shares in open-market buy - Stock Titan
Fractyl Health, Inc. 8-K Filing June 2026: Company Information, Nasdaq Listing, and Executive Details - Minichart
Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding - Insider Monkey
Fractyl Health director William Bradley buys $50,328 in stock By Investing.com - Investing.com Australia
Fractyl Health director William Bradley buys $50,328 in stock - Investing.com
Fractyl Health (NASDAQ: GUTS) 2026 meeting backs board and auditor - Stock Titan
Fractyl Health (GUTS) director buys stock and receives 22,500 options - Stock Titan
Fractyl Health (GUTS) awards 22,500 stock options to board director - Stock Titan
Fractyl Health (GUTS) awards director 22,500 options at $0.7318 - Stock Titan
Fractyl Health (GUTS) director Marc Elia receives 22,500-share stock option grant - Stock Titan
Fractyl Health (GUTS) director receives 22,500-stock-option board compensation grant - Stock Titan
Director Clive Meanwell gets 22,500 options at Fractyl Health (GUTS) - Stock Titan
Fractyl Health (NASDAQ: GUTS) director buys shares and receives options - Stock Titan
Fractyl Health (GUTS) CEO buys 25,000 open-market shares - Stock Titan
Fractyl Health (GUTS) Surges 10%: Key Levels to Watch After Breakout AttemptPre-Earnings Momentum - dars.gov.et
Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock By Investing.com - Investing.com South Africa
Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock - Investing.com
[Form 4] FRACTYL HEALTH, INC. Insider Trading Activity - Stock Titan
Fractyl Health reports one-year data on weight maintenance therapy - Investing.com UK
GUTS Reiterates by HC Wainwright & Co. -- Price Target Maintained at $8.00 - GuruFocus
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Open-Label Study of Revita Procedure for Post-GLP-1 Weight Maintenance - marketscreener.com
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - markets.businessinsider.com
Fractyl Health Highlights One-Year Revita Obesity Results - TipRanks
Fractyl Health reports one-year data on weight maintenance therapy By Investing.com - Investing.com South Africa
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Cohort, Highlighting Revita's Efficacy in Sustaining Weight Loss Post-GLP-1 Therapy - Quiver Quantitative
Revita study shows durable post-GLP-1 weight loss at Fractyl Health (GUTS) - Stock Titan
Fractyl Health Reports Positive One-Year REVEAL-1 - GlobeNewswire
Fractyl Health Reports Positive One-Year Results from REVEAL-1 Cohort, Highlighting Revita's Efficacy in Sustaining Weight Loss Post-GLP-1 Therapy | GUTS Stock News - Quiver Quantitative
Fractyl Health names Mike Zumdahl as market access head By Investing.com - Investing.com South Africa
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy - The Manila Times
Fractyl Health names Mike Zumdahl as market access head - Investing.com
Nearly 1M leave GLP-1 therapy monthly; Fractyl hires market-access lead - Stock Titan
1.17%
2.48%
자본화:
|
볼륨(24시간):